January 8, 2012 | INC Research, a therapeutically-focused clinical research organization (CRO), has selected goBalto Tracker 2.0 as its global site activation solution. Tracker, a past winner of a Bio-IT World Best Practices award, is a secure, web-based platform that enables study teams to track and manage site activation activities in clinical trials. "We chose goBalto Tracker as part of our study startup solution because it offers enhanced visibility into the traditionally cumbersome process of activating sites for clinical trials," said Alistair Macdonald, Chief Operating Officer at INC Research in a statement. "The system creates efficiencies through streamlined communication among sites, sponsors and CROs. This ultimately drives shorter timelines and cost savings for our customers." Press Release